Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

Samar Alsafadi(Université Paris Sciences et Lettres), Marc‐Henri Stern(Inserm)
Nature Communications
February 4, 2016
Cited by 383


Related Papers